Gerald T. Proehl
Net Worth
Last updated:
What is Gerald T. Proehl net worth?
The estimated net worth of Mr. Gerald T. Proehl is at least $428,335 as of 23 Nov 2021. He owns shares worth $320,175 as insider and has received compensation worth at least $108,160 in Dermata Therapeutics, Inc..
What is the salary of Gerald T. Proehl?
Mr. Gerald T. Proehl salary is $27,040 per year as Founder, Pres, Chief Executive Officer & Chairman in Dermata Therapeutics, Inc..
How old is Gerald T. Proehl?
Mr. Gerald T. Proehl is 66 years old, born in 1959.
What stocks does Gerald T. Proehl currently own?
As insider, Mr. Gerald T. Proehl owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | Founder, Pres, Chief Executive Officer & Chairman | 59,512 | $5.38 | $320,175 |
What does Dermata Therapeutics, Inc. do?
Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of hyperhidrosis and aesthetic conditions. The company was incorporated in 2014 and is headquartered in San Diego, California.
Gerald T. Proehl insider trading
Dermata Therapeutics key executives
Dermata Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Dr. Christopher J. Nardo M.P.H., Ph.D. (59) Senior Vice President of Devel.
- Dr. Maria Bedoya Toro Munera M.B.A., Ph.D. (71) Senior Vice President of Regulatory Affairs & Quality Assurance
- Mr. Gerald T. Proehl (66) Founder, Pres, Chief Executive Officer & Chairman